Canada Pension Plan Investment Board’s Tetraphase Pharmaceuticals, Inc. TTPH Stock Holding History

Canada Pension Plan Investment Board’s Portfolio TTPH Stock Details TTPH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q2	–	Sell	-5,000	Closed	-$134K	–	1605
2019 Q1	$134K	Buy	+5,000	New	+$127K	﹤0.01%	1248
2018 Q4	–	Sell	-12,500	Closed	-$690K	–	1377
2018 Q3	$690K	Buy	12,500 +10,000	+400%	+$639K	﹤0.01%	1128
2018 Q2	$179K	Buy	+2,500	New	+$177K	﹤0.01%	1148
2018 Q1	–	Sell	-127,705	Closed	-$16.1M	–	1316
2017 Q4	$16.1M	Hold	127,705	–	–	0.03%	420
2017 Q3	$17.5M	Buy	127,705 +45,000	+54%	+$6.02M	0.04%	382
2017 Q2	$11.8M	Hold	82,705	–	–	0.03%	444
2017 Q1	$15.2M	Hold	82,705	–	–	0.04%	355
2016 Q4	$6.67M	Hold	82,705	–	–	0.02%	454
2016 Q3	$6.33M	Sell	82,705 -16,106	-16%	-$1.29M	0.02%	474
2016 Q2	$8.5M	Hold	98,811	–	–	0.03%	387
2016 Q1	$9.15M	Hold	98,811	–	–	0.04%	398
2015 Q4	$19.8M	Buy	+98,811	New	+$19.7M	0.09%	174

Other funds holding TTPH

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

TCM

Tekla Capital Management Boston, Massachusetts $2.56B AUM 18.15% 1-Year Est. Return

6CM

683 Capital Management New York $1.92B AUM 85.52% 1-Year Est. Return

OAM

Oxford Asset Management Oxford, United Kingdom $232M AUM 31% 1-Year Est. Return

Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Royce & Associates New York $10.1B AUM 42.88% 1-Year Est. Return

Canada Pension Plan Investment Board's TTPH Position: Q2 2019 in Review

Canada Pension Plan Investment Board sold out of Tetraphase Pharmaceuticals, Inc. (TTPH) in Q2 2019, closing a stake of 5,000 shares — an estimated $134K sold.

Canada Pension Plan Investment Board first reported a position in TTPH in Q4 2015 and held it in 12 quarters. The position peaked at $19.8M in Q4 2015. 66 funds tracked by Wall St. Rank hold TTPH as of Q2 2019.

Canada Pension Plan Investment Board reported no remaining Tetraphase Pharmaceuticals, Inc. position as of Q2 2019 after selling out during the quarter.
Canada Pension Plan Investment Board sold 5,000 Tetraphase Pharmaceuticals, Inc. shares in Q2 2019, an estimated $134K.
Canada Pension Plan Investment Board first reported a position in Tetraphase Pharmaceuticals, Inc. in Q4 2015 and held it in 12 quarters.
Canada Pension Plan Investment Board's Tetraphase Pharmaceuticals, Inc. position peaked at $19.8M in Q4 2015.
66 funds tracked by Wall St. Rank held Tetraphase Pharmaceuticals, Inc. as of Q2 2019.

Based on Canada Pension Plan Investment Board's 13F filing for Q2 2019, filed 12 Aug 2019.